The impact of less than 8% weight loss on overall survival in subjects with non-small cell lung cancer (NSCLC) treated in a phase IIb trial of GTx-024.
S. Dodson
Employment or Leadership Position - GTx
Stock Ownership - GTx
A. Dobs
Research Funding - GTx
M. L. Hancock
Employment or Leadership Position - GTx
Stock Ownership - GTx
M. A. Johnston
Employment or Leadership Position - GTx
Stock Ownership - GTx
M. S. Steiner
Employment or Leadership Position - GTx
Stock Ownership - GTx